Cargando…

Optimized timing of using infliximab in perianal fistulizing Crohn's disease

Infliximab (IFX), as a drug of first-line therapy, can alter the natural progression of Crohn’s disease (CD), promote mucosal healing and reduce complications, hospitalizations, and the incidence of surgery. Perianal fistulas are responsible for the refractoriness of CD and represent a more aggressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xue-Liang, Chen, Shi-Yi, Tao, Shan-Shan, Qiao, Li-Chao, Chen, Hong-Jin, Yang, Bo-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167413/ https://www.ncbi.nlm.nih.gov/pubmed/32327905 http://dx.doi.org/10.3748/wjg.v26.i14.1554

Ejemplares similares

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
por: Yan, Xiaohan, et al.
Publicado: (2019)

Analysis of Risk Factors for Anorectal Stenosis of Perianal Fistulizing Crohn’s Disease
por: Xu, MinMin, et al.
Publicado: (2020)

Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018)

Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022)

Establishing a rabbit model of perianal fistulizing Crohn’s disease
por: Lu, Shuang-Shuang, et al.
Publicado: (2022)

Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era
por: Lee, Tanya, et al.
Publicado: (2020)

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
por: Ayoub, Fares, et al.
Publicado: (2022)

Perianal fistulizing Crohn's disease and overall risk of cancer: No red flag
por: McLellan, Paul, et al.
Publicado: (2023)

Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
por: Ma, Ye, et al.
Publicado: (2023)

Approach to medical therapy in perianal Crohn’s disease
por: Vasudevan, Abhinav, et al.
Publicado: (2021)

Prognostic factors affecting outcomes in fistulating perianal Crohn’s disease: a systematic review
por: Braithwaite, G. C., et al.
Publicado: (2017)

The Bottom Line: A Multidisciplinary Approach Is Key to Treating Perianal Fistulizing Crohn’s Disease
por: Nguyen, Geoffrey C
Publicado: (2018)

Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis
por: Lee, Tanya, et al.
Publicado: (2019)

Editorial: Abdominal and Perianal Fistulizing Crohn's Disease: Imaging, Surgical Techniques and Basic Research
por: Luglio, Gaetano, et al.
Publicado: (2022)

A Preclinical Validation of Iron Oxide Nanoparticles for Treatment of Perianal Fistulizing Crohn’s Disease
por: Cazelles, Antoine, et al.
Publicado: (2022)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017)

Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
por: Hong, Liwen, et al.
Publicado: (2020)

Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease
por: Thomassin, Lucie, et al.
Publicado: (2017)

Clinical characteristics and MRI-based phenotypes of perianal abscess formation in children with fistulizing Crohn's Disease
por: Tabari, Azadeh, et al.
Publicado: (2022)

A complex presentation and successful management of fistulizing perianal Crohn’s disease extending to the mid-back
por: Vazquez, Christopher, et al.
Publicado: (2023)

Internal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease
por: Fang, Xiaoli, et al.
Publicado: (2023)

Ustekinumab Promotes Radiological Fistula Healing in Perianal Fistulizing Crohn’s Disease: A Retrospective Real-World Analysis
por: Yao, Jiayin, et al.
Publicado: (2023)

Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015)

Surgical Treatment of Perianal Fistulizing Crohn's Disease: From Lay-Open to Cell-Based Therapy—An Overview
por: Pellino, Gianluca, et al.
Publicado: (2014)

Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion
por: Ali, Abeer S., et al.
Publicado: (2021)

Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?
por: Armuzzi, Alessandro, et al.
Publicado: (2022)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
por: Lee, Jong Lyul
Publicado: (2019)

Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts
por: Kang, Ben, et al.
Publicado: (2020)

Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
por: Zhu, Ping, et al.
Publicado: (2022)

Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
por: Papamichael, Konstantinos, et al.
Publicado: (2017)

Association Between Steroid-Sparing Therapy and the Risk of Perianal Fistulizing Complications Among Young Patients With Crohn Disease
por: Adler, Jeremy, et al.
Publicado: (2020)

Disease- and Medication-Specific Differences of the Microbial Spectrum in Perianal Fistulizing Crohn’s Disease—Relevant Aspects for Antibiotic Therapy
por: Kelm, Matthias, et al.
Publicado: (2022)

Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn′s Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition
por: Rizzo, Giulia, et al.
Publicado: (2022)

Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
por: Boarini, Lucas Rodrigues, et al.
Publicado: (2023)

Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn’s Disease Patients
por: van Rijn, Kyra L, et al.
Publicado: (2021)

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
por: Gu, Bonita, et al.
Publicado: (2022)

Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
por: Jeon, Myunghoon, et al.
Publicado: (2019)

Pathogenesis of Fistulating Crohn’s Disease: A Review
por: McGregor, Colleen Georgette Chantelle, et al.
Publicado: (2022)

The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
por: Wetwittayakhlang, Panu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8e8v7mogdslu41gh0l0si9gs26